Washington:
Reports indicate that Beijing is exploring options to address concerns raised by the Trump administration regarding China’s involvement in the fentanyl trade. This could, perhaps, pave the way for resuming trade talks, according to The Wall Street Journal.
Citing unnamed sources familiar with the discussions, the article mentions that Chinese Minister of Public Security, Xiaohong, recently inquired about what the Trump team expects from China concerning the chemical components used in synthesizing fentanyl.
It seems part of China’s strategy may involve sending a senior official to the U.S. to meet with top members of Trump’s administration, or possibly engaging with them in a neutral location.
However, the situation remains uncertain, with Beijing aiming to mitigate some of Trump’s trade criticisms. As of now, neither the White House nor the Chinese Embassy in Washington has responded to requests for comments.
The article underscores a warning from China’s Commerce Department against “extortion and coercion” following an offer from Washington to discuss the 145% tariffs placed on Chinese goods. Trump has associated the ongoing trade war with China—which has significantly disrupted global markets—with the fentanyl crisis, which has claimed countless American lives.
The U.S. maintains that Chinese chemical manufacturers play a major role in supplying precursor chemicals needed by drug cartels to create synthetic opioids, contributing to around 450,000 overdose deaths in the U.S. China, in response, has consistently defended its stringent drug laws and efforts against smuggling, emphasizing that the U.S. should address its own addiction issues.
On Wednesday, Trump expressed optimism about striking a deal with China, coinciding with Xi Jinping’s diplomatic call for the U.S. to adjust to the evolving international landscape, although Xi did not mention the U.S. explicitly.
Last month, sources revealed that the Trump administration had personal meetings with Chinese officials, primarily involving high-ranking staff from the Chinese embassy and the U.S. National Security Council. Yet, those talks reportedly bore no fruit, with U.S. negotiators claiming that China was not engaging in good faith.
Most recently, the Trump administration revoked tax-free access to low-value shipments coming from China and Hong Kong, dismantling the “minimum” exemption utilized by various e-commerce platforms, as well as those involved in the trafficking of fentanyl and other illicit substances.
